10 results
S-3
EX-1.2
LYEL
Lyell Immunopharma, Inc.
28 Feb 24
Shelf registration
7:49pm
Adverse Change. The Company is not party to any collective bargaining agreement.
(kk) No Finder’s Fee. None of the Company or any of its subsidiaries
S-3ASR
EX-1.2
LYEL
Lyell Immunopharma, Inc.
4 Aug 22
Automatic shelf registration
5:29pm
be expected to have a Material Adverse Effect. The Company is not party to any collective bargaining agreement.
(nn) No Finder’s Fee. None of the Company
10-K
2021 FY
LYEL
Lyell Immunopharma, Inc.
29 Mar 22
Annual report
4:20pm
therapies. Substantially all of our employees are located in California and Washington. None of our employees are subject to a collective bargaining agreement
424B4
LYEL
Lyell Immunopharma, Inc.
18 Jun 21
Prospectus supplement with pricing info
12:00am
. degrees. None of our employees is subject to a collective bargaining agreement. We consider our relationship with our employees to be good.
We
S-1/A
dmeuvln83p0enjz65q
9 Jun 21
IPO registration (amended)
7:12am
S-1/A
EX-1.1
8v1 awamj
9 Jun 21
IPO registration (amended)
7:12am
S-1
xs0ss63
25 May 21
IPO registration
5:28pm
DRS/A
jwnvxl
12 May 21
Draft registration statement (amended)
12:00am
DRS
eeihfs dpdf3osskwb
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next